Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
Standard
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men. / Jeldres, Claudio; Suardi, Nazareno; Walz, Jochen; Saad, Fred; Hutterer, Georg C; Bhojani, Naeem; Shariat, Shahrokh F; Perrotte, Paul; Graefen, Markus; Montorsi, Francesco; Karakiewicz, Pierre I.
In: EUR UROL, Vol. 54, No. 1, 1, 2008, p. 107-116.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
AU - Jeldres, Claudio
AU - Suardi, Nazareno
AU - Walz, Jochen
AU - Saad, Fred
AU - Hutterer, Georg C
AU - Bhojani, Naeem
AU - Shariat, Shahrokh F
AU - Perrotte, Paul
AU - Graefen, Markus
AU - Montorsi, Francesco
AU - Karakiewicz, Pierre I
PY - 2008
Y1 - 2008
N2 - OBJECTIVES: The life expectancy of candidates for attempted curative therapy of prostate cancer should not be inferior to 10 yr. We examined the rate of 10-yr survival in septa- and octogenarians treated for prostate cancer with either attempted curative external beam radiotherapy (EBRT) or radical prostatectomy (RP). METHODS: Within a population-based cohort of 17,570 EBRT or RP patients, 6183 men aged 70 yr or older were treated with either RP (n=1591) or EBRT (n=4592) and represented the focus of crude survival analyses. Age and Charlson Comorbidity Index represented covariates. To control for prostate cancer-specific mortality, we repeated the analyses in a subset of 2704 men (RP, n=881; EBRT, n=1823) who had no clinical evidence of disease relapse of prostate cancer. RESULTS: Overall actuarial 10-yr survival was 38.5% (RP 59.3% vs. EBRT 30.3%, p
AB - OBJECTIVES: The life expectancy of candidates for attempted curative therapy of prostate cancer should not be inferior to 10 yr. We examined the rate of 10-yr survival in septa- and octogenarians treated for prostate cancer with either attempted curative external beam radiotherapy (EBRT) or radical prostatectomy (RP). METHODS: Within a population-based cohort of 17,570 EBRT or RP patients, 6183 men aged 70 yr or older were treated with either RP (n=1591) or EBRT (n=4592) and represented the focus of crude survival analyses. Age and Charlson Comorbidity Index represented covariates. To control for prostate cancer-specific mortality, we repeated the analyses in a subset of 2704 men (RP, n=881; EBRT, n=1823) who had no clinical evidence of disease relapse of prostate cancer. RESULTS: Overall actuarial 10-yr survival was 38.5% (RP 59.3% vs. EBRT 30.3%, p
M3 - SCORING: Zeitschriftenaufsatz
VL - 54
SP - 107
EP - 116
JO - EUR UROL
JF - EUR UROL
SN - 0302-2838
IS - 1
M1 - 1
ER -